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The I5L gene is one of ~90 genes that are conserved throughout the chordopoxvirus family, and
hence are presumed to play vital roles in the poxvirus life cycle. Previous work had indicated that
the VP13 protein, a component of the virion membrane, was encoded by the I5L gene, but no
additional studies had been reported. Using a recombinant virus that encodes an I5 protein fused
to a V5 epitope tag at the endogenous locus (vI5V5), we show here that the I5 protein is expressed
as a post-replicative gene and that the ~9 kDa protein does not appear to be phosphorylated in
vivo. I5 does not appear to traffic to any cellular organelle, but ultrastructural and biochemical
analyses indicate that I5 is associated with the membranous components of assembling and mature
virions. Intact virions can be labeled with anti-V5 antibody as assessed by immunoelectron
microscopy, indicating that the C' terminus of the protein is exposed on the virion surface. Using
a recombinant virus which encodes only a TET-regulated copy of the I5V5 gene (vΔindI5V5), or one
in which the I5 locus has been deleted (vΔI5), we also show that I5 is dispensable for replication in
tissue culture. Neither plaque size nor the viral yield produced in BSC40 cells or primary human
fibroblasts are affected by the absence of I5 expression.
Background
Vaccinia virus, the prototypic poxvirus, replicates solely in
the cytoplasm of infected cells. This physical autonomy is
accompanied by genetic autonomy: the 192 kb DNA
genome, encodes ~200 proteins involved in diverse
aspects of the viral life cycle [1]. A virally encoded tran-
scriptional apparatus directs three temporally regulated
phases of gene expression, and a virally encoded replica-
tion apparatus mediates genome replication and matura-
tion. A large number of proteins contribute to the
complex process of morphogenesis, which culminates in
the production of mature virions (MV) [2]. Most MV
remain within the cell, but a subset becomes enwrapped
in two extra membranes derived from the Golgi apparatus
or late endosomal compartment; these wrapped virions
are then released by exocytosis as enveloped virions (EV)
and mediate cell-to-cell and distal spread [3,4]. Finally, a
significant number of the viral genes encode proteins that
interface with the host. Some of these proteins regulate
intrinsic cellular responses to infection such as apoptosis
and the antiviral response, whereas others represent extra-
cellular mediators that interface with cytokines and cells
of the immune system [1,5-10].
Comparison of the genomes of a large number of
orthopoxviruses has led to the identification of ~90 genes
that are fully conserved [11]. These genes are therefore
thought to encode the repertoire of proteins required for
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the poxviral life cycle. A combination of genetic, cell bio-
logical and biochemical approaches have enabled the
functional characterization of most, but not all, of these
genes. One of the gene products that had not been studied
in depth was the product of the I5L gene, which encodes
a structural protein first identified as VP13 [12]. I5 is one
of ~75 structural proteins identified by proteomic analy-
ses as localizing to either the membrane or core of the
mature poxvirus virion [2,13-15]. Core proteins include
structural proteins essential for the assembly of the virion
core, the full complement of proteins required for mediat-
ing the early phase of gene expression, and virally
encoded kinases and phosphatases. The MV membrane
contains ~20 proteins, many of which contribute to virion
morphogenesis [2]. At least 11 membrane proteins are
essential for virion entry [16-19], and others mediate the
association of virions with GAGs or laminins on the cell
surface [20-24]. Other membrane proteins appear to be
dispensable in vitro but contribute to pathogenesis in vivo
[25]. Because our laboratory has a long-standing interest
in virion morphogenesis and in the function of virion
membrane proteins, we undertook an analysis of the I5
protein.
Methods
Materials, cells and viruses
African green monkey kidney BSC40 cells and human TK-
143B cells were cultured in Dulbecco's modified Eagle
medium (DMEM) containing 5% fetal calf serum (FCS,
Invitrogen, Carlsbad, CA) at 37°C in the presence of 5%
CO2; human diploid fibroblasts (kindly supplied by S.
Terhune, Medical College of Wisconsin, Milwaukee, WI)
were cultured similarly except that the medium contained
10% FCS. Viral stocks (WR strain of vaccinia virus) were
prepared by ultracentrifugation of cytoplasmic lysates
through 36% sucrose; titration was performed on conflu-
ent monolayers of BSC40 cells, which were fixed and
stained with 0.1% crystal violet in 3.7% formaldehyde at
48 hpi. Restriction endonucleases, T4 DNA ligase, calf
intestinal alkaline phosphatase (CIP) and Taq polymerase
were purchased from Roche Applied Sciences (Indianapo-
lis, IN). Geneticin (G418 sulfate), Lipofectamine 2000,
monoclonal V5 antibody, protein molecular weight mark-
ers and DNA molecular weight standards were purchased
from Invitrogen (Carlsbad, CA). 32P-orthophosphate and
35S-methionine were purchased from Perkin-Elmer Life
and Analytical Sciences, Inc. (Boston, Mass.). Ultra pure
chemicals, Protein A sepharose and Protein G agarose
were from Sigma Aldrich (St. Louis, MO). DNA oligonu-
cleotides were synthesized by IDT (Coralville, Iowa).
Construction of recombinant viruses
Recombinant viruses were prepared as described below,
using the primers described in Table 1.
Generation of the vI5V5 virus
A) Cloning
The overlapping products of two initial PCR reactions (1:
primers PN 5'+ I5V5 3'; 2: primers I5V5 5'+ PN3') were
used together as the template for a second round of PCR
performed with primers PN 5' and PN 3'. The final prod-
uct was digested with Bam HI and cloned into pUCNEO
[26], forming pUCneo:I4-I5V5-I6. B) Isolation of the virus
by transient dominant selection with G418. Cells were
infected with wt virus and transfected with pUCneo: I4-
I5V5-I6; at 15 hpi G418 was added to select for viruses in
which the plasmid had been inserted into the viral
genome. Cells were harvested at 48 hpi and two rounds of
plaque purification were performed to purify G418R
viruses; insertion of the plasmid was confirmed by PCR
with primers specific for NEO. Two sequential rounds of
plaque purification in the absence of G418 were then per-
formed to allow recombinational resolution of the tan-
dem repeats present in this virus. To distinguish viruses
containing only the wild-type allele from those contain-
ing the V5-tagged locus, plaque isolates were screened by
PCR using primers that flank the I4 3' and I5 5' junction
(I5 SCRN 5' or 3').
Generation of the vΔindI5V5 virus
A) Cloning
The overlapping products of two initial PCR reactions (1:
primers 1 +B; 2: primers C +3') were used together as the
template for a second round of PCR performed with prim-
ers 1+3'; this product was digested with HindIII and Cla I
and cloned into pJS4-tetR (final product pJS4:tetR ↔
opI5) [27]. The final plasmid contains two transcriptional
cassettes. One drives constitutive expression of the TET
repressor (tetR), and the other contains the V5I5 ORF
under the regulation of the TET operator and the I5 pro-
moter. These two cassettes are flanked by the left and right
halves of the TK gene, which enables insertion into the
genome by homologous recombination. B) Isolation of the
virus by BrdU and G418 selection. Cells were infected with
wt virus and transfected with linearized pJS4:tetR ↔ opI5
DNA. TK- virus was isolated by two rounds of plaque puri-
fication on human TK- cells in the presence of BrdU (25
μg/ml). Plaques of the correct genotype were expanded.
To generate the final inducible virus, the endogenous I5
allele was then replaced with a NEO cassette using the I5
KO plasmid as described below.
Generation of the vΔI5 virus
A) Cloning: generation of the I5KO plasmid
Two PCR reactions were performed, one with primers I4
pUCneo Asp + I4 pUCneo Bam, and one with primers
I6pUCneo Bam/Hind + I6 pUCneo Xba. The products were
digested with Asp718 + BamHI and BamHI + XbaI, respec-
tively, and then ligated simultaneously into pBSIIKS plas-
mid DNA that had been digested with Asp718 and XbaI.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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The resultant plasmid, pBSIIKS:I4-I6, was used as the
recipient in the next round of cloning. A 1.3 kb fragment
containing the NEO gene under the regulation of a consti-
tutive viral promoter was released from pUCneo by diges-
tion with BamHI and HindIII, and the 5' overhangs were
filled in with the Klenow fragment of E. coli DNA
polymerase. The plasmid pBSIIKS:I4-I6 was linearized at
the internal BamHI site and treated with calf intestinal
alkaline phosphatase; the 5' overhangs were filled in as
described above. This linearized plasmid was then ligated
with the NEO insert; the resulting plasmid, in which por-
tions of the I4 and I6 gene flank NEO, was designated
pI5KO. B) Isolation of the virus by G418 selection. Cells were
infected with vI5V5 and transfected with pI5KO; G418R
virus was obtained by two rounds of plaque purification
in the presence of G418; correct insertion of the NEO cas-
sette and deletion of the I5 locus were confirmed by PCR.
Metabolic labeling and immunoprecipitation
Confluent monolayers of BSC40 cells were infected with
vI5V5 or wt virus (MOI 5) and metabolically labeled with
35S-methionine (100 μCi/ml) from 3–9 hpi or with 32PPi
(100 μCi/ml) from 4–8 hpi in DMEM lacking methionine
or phosphate, respectively, along with 5% FCS that had
been dialyzed against TBS. Cells were lysed in phospholy-
sis buffer (10 mM NaPO4 [pH 7.4], 100 mM NaCl, 1% Tri-
ton X-100, 0.1% SDS, 0.5% sodium deoxycholate), and
clarified lysates were incubated with either monoclonal
V5 or polyclonal F18 antisera for 4 hr on ice followed by
the addition of Protein A for 1.5 hours. Immune com-
Table 1: 
Virus Primer Name Primer Sequence *
I5V5
PN 5' 5' ATGGATCCGGAAGGGTATCTATACTTATAG 3'
I5V5 3' 5' TCCCAACAAAGGGTTAGGGATAGGTTTACCACT 3'
I5V5 5' 5' CCTAACCCTTTGTTGGGACTCGACAGTACTTAA 3'
PN 3' 5' ATGGATCCGTTGAATAAATCCTCCATC 3'
SCRN 5' 5' GTACGCTACGTACGTCAAATCCC 3'
SCRN 3' 5' GGCATAATCCGGATGTTGTGTAG 3'
VΔindI5V5
15 '  G G GGATCCAAGCTTCTAGGACTTTGTCAC 3'
B 5' CTCTATCACTGATAGGGATATTTATATCTAAAAATTAGATC 3'
C 5'CCCTATCAGTGATAGAGAATGGTGGATGCTATAAC 3'
3' 5'ATGGATCCatcgatTTAAGTACTGTCGAGTCCCAACAAAGG 
GTTAGGGATAGGTTTACCACTTTTCATTAATAGGG 3'
vΔI5
I4 pUCneo Asp 5' GCGCCCggtaccGAATAAATCCTCCATC 3'
I4 pUCneo Bam 5' CGGGATCCGTACGTAAAATCCCTATT 3'
I6pUCneo Bam/Hind 5' CGGGATCCAAGCTTCTAAAAATTAGATCAAAG 3'
I6 pUCneo Xba 5' ATTCTAGAGGCGGTGTGGATTTC 3'
*The restriction enzyme sites encoded in the primers are noted as follows: BamHI, bold; HindIII, italics; ClaI, lower case; Asp718, lowercase italics; 
XbaI, small caps.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
Page 4 of 11
(page number not for citation purposes)
plexes were washed, resolved electrophoretically, and vis-
ualized by autoradiography using a Kodak low emission
screen.
Immunoelectron microscopy
Infected cells
BSC40 cells were infected with vI5V5 (MOI 2) for 17 hr
and then fixed in situ with 4% paraformaldahyde/0.1%
glutareldahyde in PBS for 60 min at room temp. Cells
were then processed for immunoelectron microscopy and
embedded in Lowicryl K4M; grids were stained using the
V5 antibody followed by incubation with a secondary
antibody conjugated to 5 or 10 nm gold.Intact virions:
Purified vI5V5 virions (or control virions encoding a wt I5
protein lacking the V5 epitope) were applied to grids and
probed with either a control antibody (anti-A17) or the
anti-V5 antibody and a secondary antibody conjugated to
10 nm gold particles. Grids were post-stained with uranyl
acetate. All images were obtained on a Hitachi H-600
microscope.
Immunofluorescence microscopy
BSC40 cells were infected with wt virus or vI5V5 for 8 h
prior to being fixed with 4% paraformaldehyde; cells were
then incubated with the monoclonal anti-V5 antibody
and a secondary antibody conjugated to Alexafluor 594.
DAPI was included to visualize the nucleus and viral rep-
lication factories.
NP40 and DTT fractionation
wt and I5V5 virions purified by sedimentation on 25–
40% sucrose gradients were treated with NP40 (1%) or
NP40 and DTT (1% and 50 mM, respectively) [5]. The sol-
uble (S) and particulate (P) fractions, representing the
membrane and core components, respectively, were
resolved by sedimentation (16,000 × g, 30 min, room
temperature) and analyzed by immunoblot analysis with
anti-V5 and antibodies against known membrane (A17)
and core (F18) proteins.
Protease treatment
I5V5 virions (6 μg) were subjected to treatment with chy-
motrypsin (Chymo) or trypsin (Tryp) (10 μg/ml, 30 min
at 37°C) or with proteinase K (ProtK; 50 μg/ml) for 10 or
30 min at 4°C. After sedimentation at 14,000 × g, 5 min,
the soluble (S) and pellet (P) fractions were resolved and
analyzed by immunoblot analysis using anti-D8 or anti-
V5 antibodies.
Results and discussion
I5 is expressed as a post-replicative protein, does not 
appear to be phosphorylated, and is present in crescents, 
immature and mature virions
The I5L gene encodes a protein of 78 aa, which is pre-
dicted to have two highly hydrophobic domains at the N-
and C-termini and is likely to be an integral membrane
protein (Fig 1A). Indeed, VP13 was originally identified as
a component of the membrane of mature virions [12].
The protein is highly conserved in diverse chordopoxvi-
ruses, as is evident in the alignment shown in Fig 1B. To
enable a structural and functional characterization of I5,
we generated a number of recombinant viruses, for which
the key genomic features are depicted in Fig 1C. These
recombinant viruses will be discussed in more detail
throughout the remainder of this report.
First, we generated the vI5V5 virus, in which a V5 epitope
tag has been inserted at the C-terminus of the endogenous
I5 open reading frame (see Fig 1C). Immunoblot analysis
permitted the ready visualization of the I5 protein in cells
that had been infected with vI5V5, but not wild-type (WT)
virus, for 8 h (Fig 2A). However, inclusion of ara C (cyto-
sine arabinoside), which is an inhibitor of DNA replica-
tion and thus of intermediate and late gene expression,
blocked the expression of I5. Hence, I5 is expressed as a
post-replicative gene. The G7 protein, which is a known
late protein, served as an internal control for the immuno-
blot analysis [28,29]. The predicted amino acid sequence
of I5 contains a number of highly conserved serine, thre-
onine and tyrosine residues that could be modified by
phosphorylation in vivo (marked by black ovals in Fig 1B;
ser/thr present in ≥ 10 of 13 orthologs shown). Therefore,
we also performed immunoprecipitation analysis on
infected cells that had been metabolically labeled with
either 35S-met or 32PPi (Fig 2B). Although 35S-labeled I5
could be immunoprecipitated with the anti-V5 antibody,
no  32P-labeled I5 was retrieved. In contrast, both 35S-
labeled and 32P-labeled F18, a known phosphoprotein
that is expressed at post-replicative times and encapsi-
dated in the virion core, were retrieved in immunoprecip-
itations performed with the anti-F18 serum [30-33]. Thus,
it appears that the I5 protein is not phosphorylated in vivo.
To monitor the intracellular localization of I5, we used
immunofluorescence microscopy to visualize the I5 pro-
tein in cells that had been infected with vI5V5 for 8 h, or
with wt virus as a negative control. DAPI was included to
visualize nuclei and viral replication factories. As shown
in Fig 2C, the I5V5 protein showed a punctate distribution
that overlapped the viral replication factories and
extended throughout the cytoplasm. Limited background
staining was seen in cells infected with wild-type virus.
The punctate staining was consistent with localization of
I5 to intracellular membranes, although I5 was not
restricted to any sub-cellular compartment such as the ER,
the Golgi, or the plasma membrane.
Since the I5L gene encodes the protein identified as the
VP13 component of purified virions, we utilized immu-
noelectron microscopy to determine whether I5 was asso-Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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Tools for characterization and analysis of the I5 protein Figure 1
Tools for characterization and analysis of the I5 protein. (A) A Kyte-Doolittle hydrophilicity plot of the I5 protein was 
generated using the Protean module of the Lasergene software (DNASTAR, Inc.). (B) An alignment of the I5 homologs 
encoded by several chordopoxviruses is shown; sequences were obtained from http://www.poxvirus.org and aligned using the 
Megalign module of the Lasergene software. Vaccinia virus (VV, GenBank ID 29692238), camelpox virus (CMLV, GenBank ID 
18640364), ectromelia virus (EV, GenBank ID 22164721), variola virus (VAR, GenBank ID 439035), monkeypox virus (MPV, 
GenBank ID 179750543), Yaba-like disease virus (YLDV, GenBank ID 12085087), myxoma virus (MYX, GenBank ID 
18426922), molluscum contagiosum virus (MCV, GenBank ID 1492060), Shope fibroma virus (SFV, GenBank ID 18448493), 
lumpy skin disease virus (LSDV, GenBank ID 151505037), sheeppox virus (ShPV, GenBank ID 21492557), and swinepox virus 
(SPV, GenBank ID 18640187). (C) The key genomic features of three recombinant viruses used in this study are shown. In the 
vI5V5 virus, the endogenous locus has been modified such that the I5 protein is fused to a C-terminal V5 epitope tag. In the 
inducible vΔindI5V5 recombinant, the endogenous I5 ORF has been replaced by a NEO cassette, and the tetR gene and an 
inducible copy of the I5V5 ORF has been inserted into the non-essential thymidine kinase (TK) locus of the genome. The induc-
ible I5V5 ORF is under the regulation of the I5 promoter and the TET operator. The vΔI5 virus was generated by replacing the 
I5V5 locus of vI5V5 with the NEO cassette; this virus is deleted for the I5 locus. The primers and strategy used for the gener-
ation of these viruses are shown in Table 1.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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Characterization of the endogenous I5V5 protein Figure 2
Characterization of the endogenous I5V5 protein. (A). I5 is expressed as a late protein. Cells were left uninfected (lane 1) 
or infected (MOI 5) with wt virus (lane 2) or with vI5V5 in the absence (lane 3) or presence (lane 4) of AraC (cytosine arabino-
side, 20 μM). Cells were harvested at 8 hpi and lysates were probed with either an anti-G7 or anti-V5 antibody. The molecular 
masses (in kDa) of protein standards are shown at the left. (B) I5 is not phosphorylated in vivo. BSC40 cells were infected with wt 
virus (lanes 1,2,5,6) or vI5V5 (lanes 3,4,7,8) (MOI 5) in the presence of either 35S-met (lanes 1–4) or 32PPi (lanes 5–8) and then 
harvested for immunoprecipitation analysis. Immunoprecipitation was performed with antisera specific for the F18 protein 
(odd numbered lanes) or the V5 epitope (even numbered lanes); immune complexes were resolved electrophoretically and vis-
ualized by audioradiography. The molecular masses (in kDa) of protein standards are shown at the right. (C) I5 shows a punctate 
distribution throughout the cytoplasm. BSC40 cells were infected with wt virus or vI5V5 for 8 hpi; fixed cells were stained with the 
anti-V5 antibody and a secondary antibody conjugated to Alexafluor 594 and DAPI. (D) I5 localizes to crescents, immature and 
mature virions. Cells were infected with V5I5 (MOI 2) and harvested at 17 hpi for post-embedding immunoelectron microscopy. 
Sections were incubated with anti-V5 antibody and secondary antibodies conjugated to 5 nm (panels B, C, E) or 10 nm (panels 
A, D, F) gold particles.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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ciated with the classical intermediates in virion
morphogenesis (crescents and immature virions) as well
as with mature virions. As shown in Fig 2D, I5 was found
to associate with crescents (A), immature (A) and mature
virions (B-F).
I5 is encapsidated in the virion membrane, and the C-
terminus is exposed on the outer surface of intact virions
To assess the encapsidation of the I5 protein, purified
vI5V5 virions were subjected to immunoblot analysis; as
shown in Fig 3A, the I5V5 protein was readily observed.
Virions were treated with NP40 or NP40+ DTT and then
sedimented to prepare soluble (S) and pellet (P) fractions
that contained membrane and core proteins, respectively
[19,34]. The I5 protein was released into the soluble
phase after treatment with NP40 alone (or NP40+DTT)
(Fig 3B). We have previously observed that two other
small membrane proteins, I2 and A13, behave similarly
[19,34]. In contrast, the A17 protein, which is predicted to
have two membrane spanning domains, contains
intramolecular and intermolecular disulfide bonds, and
binds to the dimeric A14 protein, is only released into the
soluble phase upon treatment with both NP40 and DTT
[28,35,36]. The F18 core protein remains in the pellet
fraction after both treatments. Thus, the I5 protein is
indeed a component of the virion membrane, consistent
with the report that the I5L gene encodes the VP13 mem-
brane protein [12]. To gain some indication of the orien-
tation of I5 within the membrane, we labeled intact
virions with the anti-V5 serum and a 10 nm-gold particle-
conjugated secondary antibody. Virions produced after
infection with a virus encoding a wild-type I5 allele lack-
ing the epitope tag served as a control. The vI5V5 virions
were readily labeled with the anti-V5 serum (Fig 3C), indi-
cating that the C-terminal epitope tag is accessible on the
exterior face of virions. Detection of the A17 protein on
the surface of intact virions served as a positive control
[37].
Since the epitope was exposed, we tested the same anti-V5
antibody at dilutions ranging from 1:4 to 1:64 for its abil-
ity to neutralize the infectivity of vI5V5 virions (incuba-
tion at 45°C for 90–360 min); wild-type virions served as
a negative control. No neutralization was observed (not
shown). Finally, we treated purified vI5V5 virions with
chymotrypsin, trypsin or proteinase K and then examined
both the virion particles (P) and the supernatant fluid (S)
by immunoblot analysis with anti-V5 and anti-D8 sera.
The D8 protein was readily cleaved by all three proteases,
as has been observed before [38]. No cleavage or loss of
the anti-V5 immunoreactive signal was observed after
treatment of the virions with trypsin or chymotrypsin.
After proteinase K treatment, however, we noted a moder-
ate loss of the I5V5 protein: only ~35% of the immunore-
active signal remained after 30 min of digestion. We
interpret these data as evidence that proteinase K can trim
the V5-tagged C-terminus of the protein, albeit ineffi-
ciently. Because we did not observe any significant change
in electrophoretic mobility of the V5-tagged protein, it
appears that neither the N-terminus nor the central loop
region of the I5V5 protein is readily accessible to protease
in intact virions.
Analysis of an inducible recombinant in which expression 
of I5V5 is TET-dependent: repression of I5 does not 
compromise viral replication in BSC40 cells or human 
diploid fibroblasts
To enable a functional characterization of the role of the
I5 protein in viral replication, we generated the viral
recombinant vΔindI 5 V 5  ( s e e  F i g  1 C ) .  T o  g e n e r a t e  t h i s
recombinant, we first inserted a bidirectional cassette
encoding TetR (a transcriptional repressor) and an induc-
ible copy of the I5V5 gene into the non-essential TK locus
of wild-type vaccinia virus, as we have done before for the
F10, A13 and I2 genes [19,27,39]. The inducible I5V5
gene is regulated by the endogenous I5 promoter and
TetO (the Tet operator). The endogenous I5 locus was
then replaced with a NEO cassette that conferred resist-
ance to G418. Our characterization of this virus is shown
in Fig 4. Immunoblot analysis showed that, in two iso-
lates of vΔindI5V5, expression of the I5V5 protein was
indeed TET-dependent (panel A, compare lanes 1, 3 with
2, 4). As expected, however, the I3 single-strand DNA
binding protein (expressed early, intermediate) and the
L4 core protein (expressed late) were expressed under all
experimental conditions. Moreover, the relative abun-
dance of both the precursor and processed forms of L4
(upper and lower bands, respectively) was unchanged
when I5 was repressed. Since proteolytic processing of the
core proteins is coupled to virion morphogenesis, this
observation also suggested that repression of I5 might not
have any impact on the completion of the viral life cycle
[40,41]. Indeed, when we monitored the yield of infec-
tious virus produced at 24 hpi in BSC40 cells (MOI 3), we
found that repression of I5 had no impact (panel B, left
graph). To assess whether this result would also hold true
in primary cells that more closely mimicked replication in
vivo, we performed the same experiment in primary
human foreskin fibroblasts. In this case, too, repression of
I5 had no impact on the yield of infectious, cell-associated
virus (panel B, right graph).
Generation of a virus lacking an I5 allele: vΔI5 replicates 
well in BSC40 cells and human diploid fibroblasts
The results described above strongly suggested that the I5
protein was dispensable in tissue culture; to confirm this
result, we generated the vΔI5 virus whose genomic struc-
ture is shown in Fig 1C. To make this virus, we began with
the vI5V5 virus, and replaced the I5V5 allele with the NEO
cassette. This virus was readily isolated, suggesting that theVirology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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Analysis of the I5 protein found within mature virions Figure 3
Analysis of the I5 protein found within mature virions. (A) I5 is encapsidated within mature virions. Increasing concentra-
tions of purified I5V5 virions (0.5, 0.8, 2 μg) were subjected to immunoblot analysis and probed with the anti-V5 antibody. The 
9 kDa I5V5 protein was readily visualized; the molecular masses (in kDa) of protein standards are shown at the right. (B). I5 is 
found within the virion membrane. wt and I5V5 virions purified by sedimentation on 25–40% sucrose gradients were treated with 
NP40 or NP40 and DTT (5). The soluble (S) and particulate (P) fractions, representing the membrane and core components, 
respectively, were resolved by sedimentation and analyzed by immunoblot analysis with anti-V5 and antibodies against known 
membrane (A17) and core (F18) proteins. (C) The V5 epitope is accessible on the surface of intact I5V5 virions. Purified vI5V5 viri-
ons (or a control virus encoding a wt I5 protein lacking the V5 epitope) were applied to grids and probed with either a control 
antibody (anti-A17) or the anti-V5 antibody and a secondary antibody conjugated to 10 nm gold particles. (D). Proteolytic treat-
ment of vI5V5 virions. I5V5 virions (6 μg) were subjected to treatment with chymotrypsin (Chymo) or trypsin (Tryp) for 30 min 
or with proteinase K (ProtK) for 10 or 30 min. After sedimentation at 14,000 × g, 5 min, the soluble (S) and pellet (P) fractions 
were resolved and analyzed by immunoblot analysis using anti-D8 (top panel) or anti-V5 (lower panel) antibodies. The molecu-
lar masses (in kDa) of protein standards are shown at the right.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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I5L gene was indeed nonessential in tissue culture. To
ensure that the genomic structure of the virus was as
designed, we performed a number of diagnostic PCR
assays to ensure that no I5 allele was present anywhere in
the genome and that the NEO cassette had been inserted
between the I4L and I6L genes. The results of all of these
tests confirmed the correct insertion of the NEO cassette
(not shown). The immunoblot in Fig 4C illustrates the
loss of I5V5 expression in two isolates of vΔI5. Quantita-
tion of the 24 h viral yield produced in both BSC40 cells
and human diploid fibroblasts in shown in Fig 4D: com-
parable results were obtained with wild-type virus, vI5V5,
and vΔI5. We also performed 48 h plaque assays with
vI5V5, vΔindI5V5 + and - TET, and vΔI5 on BSC40 cells,
and observed that the plaques formed by each of these
viruses were indistinguishable in size (4E). Finally, we
Repression or deletion of the I5 locus does not have a deleterious effect on virus replication in tissue culture Figure 4
Repression or deletion of the I5 locus does not have a deleterious effect on virus replication in tissue culture. 
(A) The vΔindI5V5 virus allows tight repression of the I5 protein. BSC40 cells were infected (MOI 2) with vΔindI5V5 in the presence 
(lanes 1,3) or absence (lanes 2,4) of TET. Cells were harvested at 17 hpi and lysates were subjected to immunoblot analysis 
with the anti-V5 serum (lower panel) or antibodies specific for the intermediate and late viral proteins I3 and L4, respectively 
(top panel). The molecular masses (in kDa) of protein standards are shown at the right. (B) Repression of I5 does not affect the 
viral yield produced in a single infectious cycle in BSC40 cells or primary human fibroblasts. BSC40 cells or primary human fibroblasts 
were infected with vΔindI5V5 (MOI 3) in the presence or absence of TET and harvested at 24 hpi. Viral yield (pfu/ml) was 
determined by titration on BSC40 cells; experiments were preformed in duplicate and titrated in duplicate. Error bars repre-
sent standard deviation. (C) The vΔI5 virus is deleted for the I5 locus. Cells were infected with the parental vI5V5 virus (lanes 2,4) 
or with two isolates of the vΔI5 virus (lanes 1,3) at an MOI 2 and harvested at 18 hpi. Lysates were examined by immunoblot 
analysis with the anti-V5 antibody. The molecular masses (in kDa) of protein standards are shown at the right. (D) Deletion of I5 
does not affect the viral yield produced in a single infectious cycle in BSC40 cells or primary human fibroblasts. BSC40 cells or human 
diploid fibroblasts were infected with wt virus, vI5V5 or vΔI5 (MOI 3) for 24 h, and the viral yield was determined as described 
for panel B. (E) Repression or deletion of I5 does not affect viral plaque size. BSC40 cells were infected with 50–75 PFU of vI5V5, 
vΔindI5V5 + TET, vΔindI5V5 – TET, or vΔI5; plates were fixed and stained with crystal violet at 48 hpi.Virology Journal 2008, 5:148 http://www.virologyj.com/content/5/1/148
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compared the thermolability of vI5V5 and vΔI5 virions by
incubating inocula at 45°C for 90 to 360 min and then
performing plaque assays; the absence of I5 had no
impact on virus stability in this assay (not shown). Cumu-
latively, our data indicate that I5 is dispensable for repli-
cation in both BSC40 cells and human diploid fibroblasts.
Although the I5 protein is dispensable in tissue culture, its
conservation in the genomes of diverse orthopoxviruses
suggests that it is likely to have an important role in vivo.
Indeed, during the preparation of this manuscript, Sood et
al reported that I5 does make a significant contribution to
the pathogenesis of vaccinia virus in murine models of
infection [42]. Because the protein does not show any pre-
ferred localization to an intracellular organelle, but is
present in developing and mature virions, we propose
that it is the encapsidated pool of I5 that would modulate
pathogenesis. The protein is highly hydrophobic in
nature, and we know that both termini of the protein are
likely to be exposed on the virion surface. I5 might play a
role in enabling vaccinia virus to infect certain cell types in
vivo, it might stabilize the virus in vivo, or it might bind to
cellular ligands in a manner that facilitates infection. Fur-
ther study of how this small and highly conserved constit-
uent of the virion membrane contributes to pathogenesis
will certainly be of interest.
Conclusion
The 78 aa vaccinia-encoded I5 protein is highly hydro-
phobic and expressed at late times after infection. I5 is
found associated with intermediates in virion morpho-
genesis as well as mature virions. The C' terminus of I5 is
exposed on the surface of intact virions. Repression of I5
expression has no apparent impact on the yield of infec-
tious virus in either BSC40 cells or human diploid fibrob-
lasts; the ability to isolate a virus deleted for the I5L gene
supports the conclusion that it is dispensable for replica-
tion in tissue culture.
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